Raed Abughazaleh completed his undergraduate studies at Earlham College then spent two years working in head and neck cancer research before deciding to pursue his education in pharmacy at the University of Minnesota College of Pharmacy. After graduating with his Pharm.D. degree with honors he spent a year in residency training in Critical Care Pharmacy at Hennepin County Medical Center (HCMC) in Minneapolis, Minnesota. During his residency training Dr. Abughazaleh conducted and eventually published a study on the safety of hypertonic saline in patients with severe traumatic brain injury. After graduaing from residency, Dr. Abughazaleh was hired by HCMC as clinical pharmacist where he worked for the next five years primarily in surgery, burn, and intensive care units. In 2014 Dr. Abughazaleh returned to his home country of Palestine to work as assistant professor at Birzeit University's newly established Pharm.D. program, where he helped build its clinical components and taught the therapeutics series of courses. He also helped establish the clinical rotation program for 6th year students and currently supervises it and continues to help in developing it. Dr. Abughazaleh's current research interests include infectious disease and antibiotic resistance surveillence.
1) Abughazaleh RD, Jancik JT, Paredes-Andrade E, Solid CA, Rockswold GL. Safety of intravenous hypertonic saline administration in severe traumatic brain injury. Ann Pharmacother 2012;46(10):1441-2
2) Abughazaleh RD, Tracy TS: Therapeutic Index. In D’Agostino RB, Sullivan L, Massaro J (Eds): Wiley Encyclopedia of Clinical Trials: Therapeutic Index. Wiley & Sons, 2008.
3) Abughazaleh RD, Burkhardt RT, Straka RJ. Multivariate analysis of the determinants of triglyceride response to fenofibrate. Poster presentation, University of Minnesota College of Pharmacy Research Day, Minneapolis, MN. March 2006
4) Abughazaleh RD, Cipolle CL, Cipolle RJ, Strand LM, Frakes MJ, Schondelmeyer SW. Developing a pharmaceutical care plan reference template: helping students learn and apply pharmaceutical care for common medical conditions. Poster presentation, University of Colorado Pharmacy Student Conference, June 2005
5) Avis I, Martinez A, Tauler J, Zudaire E, Mayburd A, Abu-Ghazaleh R, Ondrey FG, Mulshine J. Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition. Cancer Research 2005; 65(10): 4181-90
6) Abughazaleh RD, Caicedo EE, Ondrey FG. Antineoplastic effects of PPAR-gamma agonists in aerodigestive squamous cell carcinoma cell lines. Poster presentation, American Association for Cancer Research (AACR) annual meeting, Orlando, FL. April 2004
7) Harris G, Ghazallah RA, Nascene D, Wuertz B, Ondrey FG. PPAR activation and decreased proliferation in oral carcinoma cells with 4-HPR. Otolaryngology-Head and Neck Surgery 2005; 133(5):695-701
8) King TA, Abu Ghazaleh R, Juhn SK, Adams GL, Ondrey FG. Induction of heat shock protein 70 inhibits NF-kappa-B in squamous cell carcinoma. Otolaryngology-Head and Neck Surgery 2005; 133(1):70-79
9) Abughazaleh RD, Cipolle C, Cipolle RJ, Strand L, Frakes MJ, Schondelmeyer SW. Pharmaceutical Care Plan Guidelines. Peters Institute of Pharmaceutical Care, University of Minnesota, Minneapolis, MN. 2004.